Primary |
Product Used For Unknown Indication |
19.3% |
Breast Cancer |
13.2% |
Colon Cancer |
11.5% |
Breast Cancer Metastatic |
8.7% |
Colorectal Cancer |
7.4% |
Drug Use For Unknown Indication |
6.5% |
Gastric Cancer |
5.5% |
Rectal Cancer |
5.4% |
Colorectal Cancer Metastatic |
3.7% |
Colon Cancer Metastatic |
3.3% |
Hypertension |
2.5% |
Rectal Cancer Metastatic |
2.1% |
Pain |
1.8% |
Large Intestine Carcinoma |
1.7% |
Pancreatic Carcinoma |
1.6% |
Metastatic Gastric Cancer |
1.4% |
Neoplasm Malignant |
1.3% |
Prophylaxis |
1.1% |
Colon Cancer Recurrent |
1.1% |
Oesophageal Carcinoma |
0.9% |
|
Death |
46.9% |
Disease Progression |
10.8% |
Vomiting |
7.5% |
Palmar-plantar Erythrodysaesthesia Syndrome |
5.2% |
Diarrhoea |
4.6% |
Malignant Neoplasm Progression |
4.5% |
Weight Decreased |
2.7% |
Stomatitis |
2.1% |
Thrombocytopenia |
1.8% |
Nausea |
1.6% |
White Blood Cell Count Decreased |
1.5% |
Pyrexia |
1.5% |
Sepsis |
1.3% |
Neoplasm Malignant |
1.3% |
Interstitial Lung Disease |
1.2% |
Mucosal Inflammation |
1.2% |
Skin Exfoliation |
1.1% |
Metastases To Liver |
1.1% |
Renal Failure |
1.1% |
Intestinal Obstruction |
1.0% |
|
Secondary |
Breast Cancer |
21.4% |
Product Used For Unknown Indication |
11.7% |
Breast Cancer Metastatic |
9.4% |
Colon Cancer |
6.5% |
Drug Use For Unknown Indication |
6.4% |
Gastrooesophageal Cancer |
6.0% |
Colon Cancer Metastatic |
5.0% |
Rectal Cancer |
4.6% |
Gastric Cancer |
4.2% |
Prophylaxis |
4.0% |
Colorectal Cancer Metastatic |
3.9% |
Colorectal Cancer |
3.2% |
Rectal Cancer Metastatic |
2.7% |
Hypertension |
2.4% |
Pain |
1.7% |
Cancer Pain |
1.7% |
Metastatic Gastric Cancer |
1.7% |
Large Intestine Carcinoma |
1.4% |
Metastases To Bone |
1.1% |
Pancreatic Carcinoma |
1.1% |
|
Vomiting |
14.0% |
Death |
13.1% |
Palmar-plantar Erythrodysaesthesia Syndrome |
12.1% |
Diarrhoea |
7.7% |
Disease Progression |
7.1% |
Pulmonary Embolism |
5.1% |
Stomatitis |
5.1% |
Weight Decreased |
4.8% |
Rash |
4.1% |
White Blood Cell Count Decreased |
3.8% |
Pyrexia |
3.6% |
Nausea |
3.5% |
Thrombocytopenia |
2.5% |
Renal Failure Acute |
2.4% |
Sepsis |
2.3% |
Malignant Neoplasm Progression |
2.1% |
Neuropathy Peripheral |
1.9% |
Neutropenia |
1.8% |
Decreased Appetite |
1.6% |
Fatigue |
1.6% |
|
Concomitant |
Breast Cancer |
32.5% |
Metastases To Bone |
13.8% |
Breast Cancer Metastatic |
12.6% |
Drug Use For Unknown Indication |
6.1% |
Premedication |
5.5% |
Product Used For Unknown Indication |
4.8% |
Colon Cancer |
4.3% |
Pain |
3.2% |
Prophylaxis |
2.5% |
Hypertension |
2.2% |
Colorectal Cancer Metastatic |
1.6% |
Breast Cancer Recurrent |
1.6% |
Depression |
1.4% |
Colorectal Cancer |
1.3% |
Chemotherapy |
1.2% |
Nausea |
1.2% |
Cancer Pain |
1.1% |
Diabetes Mellitus |
1.1% |
Colon Cancer Metastatic |
1.1% |
Prophylaxis Of Nausea And Vomiting |
1.0% |
|
Vomiting |
13.8% |
Tooth Extraction |
9.7% |
Diarrhoea |
9.1% |
Weight Decreased |
8.4% |
Nausea |
6.8% |
Death |
6.5% |
Rash |
5.7% |
Pyrexia |
4.8% |
Osteonecrosis |
4.3% |
Palmar-plantar Erythrodysaesthesia Syndrome |
4.2% |
Fatigue |
3.8% |
Toothache |
3.5% |
Disease Progression |
3.1% |
Vision Blurred |
3.0% |
Stomatitis |
2.4% |
White Blood Cell Count Decreased |
2.3% |
Wound Dehiscence |
2.3% |
Neoplasm Malignant |
2.2% |
Wound Debridement |
2.2% |
Malaise |
1.9% |
|
Interacting |
Colon Cancer Metastatic |
13.8% |
Hypertension |
10.7% |
Large Intestine Carcinoma |
10.2% |
Product Used For Unknown Indication |
9.2% |
Diabetes Mellitus |
7.1% |
Atrial Fibrillation |
6.1% |
Drug Use For Unknown Indication |
6.1% |
Breast Cancer |
4.6% |
Anaemia |
3.6% |
Analgesic Therapy |
3.6% |
Benign Prostatic Hyperplasia |
3.6% |
Constipation |
3.6% |
Colorectal Cancer Metastatic |
3.1% |
Epilepsy |
2.6% |
Mitral Valve Incompetence |
2.6% |
Prophylaxis Of Nausea And Vomiting |
2.6% |
Breast Cancer Metastatic |
2.0% |
Colon Cancer Stage Iv |
2.0% |
Colon Cancer |
1.5% |
Gastric Cancer |
1.5% |
|
White Blood Cell Count Decreased |
11.6% |
Epilepsy |
9.3% |
Prothrombin Time Prolonged |
9.3% |
Faeces Discoloured |
7.0% |
Palmar-plantar Erythrodysaesthesia Syndrome |
7.0% |
Subdural Haematoma |
7.0% |
Toxicity To Various Agents |
7.0% |
Cough |
4.7% |
Drug Interaction |
4.7% |
Pyrexia |
4.7% |
Rash |
4.7% |
Stomatitis |
4.7% |
Bone Marrow Failure |
2.3% |
Gastrointestinal Haemorrhage |
2.3% |
Hallucination, Visual |
2.3% |
International Normalised Ratio Fluctuation |
2.3% |
International Normalised Ratio Increased |
2.3% |
Mononeuropathy Multiplex |
2.3% |
Myocardial Infarction |
2.3% |
Syncope |
2.3% |
|